millipex human bone metabolism magnetic bead kit (Merck KGaA)
90
Structured Review
Merck KGaA
millipex human bone metabolism magnetic bead kit
Millipex Human Bone Metabolism Magnetic Bead Kit, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bone+metabolism+kit/milliplex+map+human+bone+magnetic+bead+kit/pmc11273725-123-27-34
Average 90 stars, based on 1 article reviews
Millipex Human Bone Metabolism Magnetic Bead Kit, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+bone+metabolism+kit/milliplex+map+human+bone+magnetic+bead+kit/pmc11273725-123-27-34
Average 90 stars, based on 1 article reviews
millipex human bone metabolism magnetic bead kit - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Injectable synthetic hydrogel for bone regeneration: Physicochemical characterisation of a high and a low pH gelling system. Article Snippet: Article Title: Prevalence of low bone mass and changes in vitamin D levels in human immunodeficiency virus-infected adults unexposed to antiretrovirals. Article Snippet: Clinical Proteomics:Article Title: Leptin as an obesity marker in rheumatoid arthritis. Article Snippet: The determination of excess of body fat mass provides a more suitable determinant of obesity in rheumatoid arthritis patients; however, body mass index (BMI) may not be accurate for the quantification of adiposity.. To identify a marker of excess adiposity in women with rheumatoid arthritis (RA) using different methods for fat mass evaluation.. A cross-sectional study was conducted in adult female patients with RA. Article Title: Negative impact of high cumulative glucocorticoid dose on bone metabolism of patients with myasthenia gravis. Article Snippet: This current study aimed to evaluate the frequency of low bone mass, osteopenia, and osteoporosis in patients with myasthenia gravis (MG) and to investigate the possible association between bone mineral density (BMD) and plasma levels of bone metabolism markers.. Eighty patients with MG and 62 controls BMDweremeasured in the right femoral neck and lumbar spine by dual-energy X-ray absorptiometry.. Plasma concentrations of osteocalcin, osteopontin, osteoprotegerin, tumor necrosis factor (TNF-α), interleukin (IL)-1β, IL-6, dickkopf (DKK-1), sclerostin, insulin, leptin, adrenocorticotropic hormone, parathyroid hormone, and fibroblast growth factor (FGF-23) were analyzed by Luminex®. |